Forecast

There is no analyst data available for this company.

News Go to news feed

Bioextrax Registered: revenue forecast sharply higher, EPS still negative

Bioextrax Registered plans to present the figures for the quarter ending 30.09.2025 on 21.11.2025. One analyst estimates EPS at -0.110 SEK (same level as last year) and expects revenue of 0.6 million SEK (+177% year-on-year). For the fiscal year a loss per share of -0.430 SEK (previously -0.520) and annual revenue of 2.1 million SEK are forecast. » More on finanzen.net

Financials

In the last quarter, BIOEXTRAX AB had revenue of €11.73K and net profit of -€442.79K

(EUR)	June 2026	YoY
Revenue	11.73K	70.82%
Gross profit	-456.6K	3,491.77%
Net profit	-442.79K	12.57%
EBITDA	-435.03K	18.20%

Fundamentals

Metric	Value
Market capitalization	€10.2M
Number of shares	47.6M
52-week high/low	€0.36 - €0.14
Dividends	No
Beta	1.49
P/E ratio	-5.48
PEG ratio	17.29
P/B ratio	9.46
P/S ratio	207.88

Company profile

Bioextrax AB (publ) entwickelt und vermarktet eine biobasierte Extraktionsplattformtechnologie. Das Unternehmen gewinnt Biokunststoffe (PHA-Granulat), organisches hydrolysiertes Protein, Keratinfasern, Bioöle, proteinreiche Nebenprodukte und Aminosäuren aus Bakterien. Das Unternehmen wurde im Jahr 2014 gegründet und hat seinen Sitz in Lund, Schweden.